Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients.

European journal of dermatology : EJD - 1 Jan 2000

Kanitakis Jean, Baldassini Sylvie, Lora Viviana, Euvrard Sylvie

Abstract excerpt

BRAF is a gene of the RAF family of kinases, frequently mutated in benign and malignant melanocytic tumors (nevi and melanomas). Organ transplant recipients are at high risk for developing various tumors, including melanocytic ones. We studied a group of 129 melanocytic tumors including various subtypes of nevi (n: 114) and melanomas (n: 15) excised from transplant (n: 63) and control (non-immunosuppressed)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Melanoma
Share to Nevus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Organ Transplantation

Share to Proto-Oncogene Proteins B-raf

Share to Sequence Analysis, DNA

Share to Skin Neoplasms

Share to Young Adult

Source

Identifiers

PMID: 19919912
DOI: 10.1684/ejd.2010.0843

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients.PMID 19919912Read ↗

Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients.Semantic proximity Read ↗

Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.Semantic proximity Read ↗

T1799A BRAF mutations in conjunctival melanocytic lesions.Semantic proximity Read ↗

Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.Semantic proximity Read ↗

Epidemiology of keratinocyte carcinomas after organ transplantationSemantic proximity Read ↗

Activating BRAF mutations in eruptive melanocytic naevi.Semantic proximity Read ↗

Low frequency of allelic loss in skin tumours from immunosuppressed individuals.Semantic proximity Read ↗

BRAF and GNAQ mutations in melanocytic tumors of the oral cavity.Semantic proximity Read ↗

Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repairSemantic proximity Read ↗

Dermatologic findings in renal transplant recipients: Possible effects of immunosuppression regimen and p53 mutations.Semantic proximity Read ↗

Polyclonality of BRAF mutations in acquired melanocytic nevi.Semantic proximity Read ↗

Role of oncogenic pathways and KRAS/BRAF mutations in the behavior of colon adenocarcinoma in renal transplant patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.